Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorder
Keywords: Epstein-Barr virus infections; hematopoietic stem cell transplantation; herpesvirus 4; post-transplantation lymphoproliferative disorders; retrospective studies; rituximab; thymoglobulin;